# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-049655
Filing Date
2022-04-25
Accepted
2022-04-25 16:22:07
Documents
11
Period of Report
2022-06-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm223704-1_def14a.htm | DEF 14A | 534845
2 | GRAPHIC | lg_sellaslifesciences-4clr.jpg | GRAPHIC | 25917
3 | GRAPHIC | sg_angelosmstergiou-bw.jpg | GRAPHIC | 9431
4 | GRAPHIC | sg_barbaraawood-bw.jpg | GRAPHIC | 9961
5 | GRAPHIC | tm223704d1-icon_internetbw.jpg | GRAPHIC | 4143
6 | GRAPHIC | tm223704d1-icon_mailbw.jpg | GRAPHIC | 1986
7 | GRAPHIC | tm223704d1-icon_telebwlr.jpg | GRAPHIC | 2489
8 | GRAPHIC | tm223704d1-pxy_proxy14c.jpg | GRAPHIC | 1514535
9 | GRAPHIC | tm223704d1-pxy_proxy24c.jpg | GRAPHIC | 1042992
10 | GRAPHIC | tm223704d1-pxy_proxy34c.jpg | GRAPHIC | 978505
11 | GRAPHIC | tm223704d1-pxy_proxy44c.jpg | GRAPHIC | 872591
| Complete submission text file | 0001104659-22-049655.txt |  | 6675780

Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 22849953
SIC: 2834 Pharmaceutical Preparations